Abstract

Unlicensed Transdermal Medications in Feline Patients: Three Case Reports

Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael

Issue: Nov/Dec 2022 - Volume 26, Number 6

Page(s): 468-472

Download in electronic PDF format for $75
  • Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Page 1
  • Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Page 2
  • Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Page 3
  • Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Page 4
  • Unlicensed Transdermal Medications in Feline Patients: Three Case Reports Page 5

Abstract

In veterinary clinical practice, conventional pharmacological treatments such as commercial capsules, tablets, or oral liquids may be difficult to administer to feline patients. Noncompliance, which is estimated to account for the majority of treatment failures, may potentially be overcome with alternative, customized treat- ment options such as topically applied, permeation-enhancing (transdermal) unlicensed medications. These medications allow for the percutaneous absorption of drugs into and through the animal’s skin, bypassing the first-pass metabolism, potentially allowing for greater bioavailability, and thus decreasing dosage to achieve therapeutic effects. In these case reports, the efficacy of two unlicensed transdermal medications is demonstrated by the successful treatment of three feline patients, refractory to conventional pharmacotherapy. In case 1, the veterinary physician prescribed gabapentin 10 mg/0.1 mL topical Lipoderm, a permeation-enhancing base, to be applied three times a day inside the cat’s ear, in order to manage the unconscious fits following a road traffic accident. In cases 2 and 3, two cats were prescribed fluoxetine 40-mg/g topical Lipoderm, to be applied once a day, in order to manage the inappropriate behavior (urination and defecation). Following three months of transdermal treatment, the quality of life of the three cats and their owners increased considerably, as demonstrated by the results of the validated, Health Related Quality of Life questionnaires employed before treatment (retrospectively) and after treatment. Permeation-enhancing (transdermal) medications are a promising dosage form in veterinary pharmacotherapy. The benefits and versatility of these alternative, customized treatment options are worth considering in current therapeutics.

Related Keywords

  • veterinary compounding
  • case reports
  • cats
  • felines
  • topical preparations
  • transdermal administration
  • permeation-enhancing excipients
  • seizure disorder
  • gabapentin
  • formulations
  • behavioral disorders
  • inappropriate urination and defecation
  • fluoxetine

Related Categories

  • EXCIPIENTS
  • FORMULATIONS
  • VETERINARY
  • CASE REPORTS
  • DOSAGE FORMS/DRUG CARRIERS

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2003
Pg. 106-113
Veterinary Transdermal Medications: A to Z
Author(s): Davidson Gigi S
Nov/Dec 2022
Pg. 468-472
Unlicensed Transdermal Medications in Feline Patients: Three Case Reports
Author(s): Urwin Craig, Jean Linda, Carvalho Maria, Robson-Laws Michael
Sep/Oct 2008
Pg. 392-397
Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Author(s): Mixon William, Helms Scott R
Nov/Dec 2010
Pg. 488-491
Case Report: Management of Secondary Hypertension in a Feline with the Use of Transdermal Prazosin
Author(s): Rudner Shara, Browne Paul
Nov/Dec 2006
Pg. 418
Case Report: Transdermal Fluoxetine as Therapy for Feline Anxiety
Author(s): Fields Shannon W
May/Jun 2010
Pg. 215-217
Compounding Gabapentin Suspension for Lower Back Pain in an Older Cat: A Case Report
Author(s): Muller George
Jul/Aug 2016
Pg. 271-274
Compounding Transdermal Medication for Feline Patients
Author(s): Eichstadt Lauren R
May/Jun 2017
Pg. 205-211
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report
Author(s): Jones Nat, Carvalho Maria, Branvold-Herr Andrea
Jan/Feb 2009
Pg. 6-12
Compounding for Pediatric Patients: Case Reports and Formulations
Author(s): Mixon William, Angelle Patricea, Yoch Douglas
Sep/Oct 2009
Pg. 386-389
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses
Author(s): Williams LaVonn A, Fokken Dawn
Sep/Oct 2007
Pg. 390-395
Submitting Compelling Case Reports for Drug Therapy in Veterinary Patients
Author(s): Davidson Gigi S
Nov/Dec 2017
Pg. 446-452
Feline Transdermal Formulation Considerations
Author(s): Forsythe Lauren Eichstadt
Jan/Feb 2011
Pg. 27-31
Goliath: Case Report on a Canine Case of Epilepsy
Author(s): Ameijeiras Carlos, Ray Jody, Jordan Dinah G, Garcia Abby Furr
May/Jun 2011
Pg. 194-199
Case Report: The Use of Topical Concentrated Capsaicin Cream to Treat Erythromelalgia in a Pediatric Patient
Author(s): McElhiney Linda F
Nov/Dec 2008
Pg. 498-504
Case Reports: Compounding to Relieve Arthritis Pain
Author(s): Marshall Robert, Vidaurri Vincent A, Boomsma Diane, Buchta Anthony J, Vail Jane
Jan/Feb 2017
Pg. 22-27
Case Report: Diabetic Foot Ulcer Infection Treated with Topical Compounded Medications
Author(s): Agbi Kelechi E, Carvalho Maria, Phan Ha, Tuma Cristiane
Sep/Oct 2014
Pg. 366-369
To Compound or Not to Compound: A Veterinary Transdermal Discussion
Author(s): Eichstadt Lauren R, Davidson Gigi S
May/Jun 2011
Pg. 200-203
Extemporaneous Preparation of Sertraline Cream for Transdermal Administration
Author(s): Wynn Tom, Goetsch Daniel
Jan/Feb 2012
Pg. 44-49
Case Studies of Compounded Tramadol Use in Cats
Author(s): Ray Joel, Jordan Dinah, Pinelli Chris, Fackler Bethany, Boggess Donan, Clark Justin
Jul/Aug 2001
Pg. 282-283
Evaluating Transdermal Medication Forms for Veterinary Patients, Part 3: Methimazole
Author(s): Davidson Gigi S